Observational Study of Lyzme5 Impact on Cholesterol and Body Weight in Man
Stopped early · Not applicable · Has a placebo group
Conditions studied: Overweight, Elevated Cholesterol
In brief
This observational placebo-controlled pilot study is intended to document whether or not Lyzme5, an over-the-counter (OTC) proprietary nutritional supplement product can positively impact, (a) weight and, (b) cholesterol levels in man.
Key facts
- Study ID
- NCT01634646
- Run by
- Jeff Golini
- People needed
- 19
- Starts
- 2012-05-01
- Expected to finish
- 2013-01-01
- Last updated by the study team
- 2013-07-16
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- At least 21 years of age or older;
- Able to read, understanding, and signing a consent form;
- Not pregnant or breast feeding (female only);
- Have normal bio-markers for liver and kidney function (determined by blood test);
- Being at least 15 lbs over your ideal weight as defined by the Body Mass Index [BMI] chart;
- Have a total cholesterol level of or in excess of 200 mg/dl (determined by blood test);
- Not using any illegal substances, including marijuana (medicinal or otherwise);
- Not using any "recreational drugs"
- Weighing less than 300 lbs
You may not qualify if…
- Under 21 years of age;
- Mentally impaired;
- Pregnant or breast feeding;
- A diabetic;
- Having digestion problems;
- Problems with kidneys, heart, or liver;
- Having, or have had cancer;
- Taking a prescription;
- Weight of 300 lbs or over;
- Total cholesterol under 200 mg/dl;
- Using "recreational" drugs.
Where it is running
- All American Pharmaceutical and Natural Foods Corporation — Billings, Montana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.